Settlement For Alzheimer’s Patent

FDG-PET_brain_scan-normal-MCI-Alzheimers

“Alzheimer’s is the cleverest thief, because she not only steals from you, but she steals the very thing you need to remember what’s been stolen. 
”
― Jarod Kintz.

In the pharmaceutical world, there is always a new drug or treatment to cure, suspend growth of, or prevent a disease/illness. Just like any other business, the competition is steep and each company is trying to produce “the cure.” Recently, Eli Lilly & Company and Johnson & Johnson both have been in the process of developing potential treatment for Alzheimer’s disease. Alzheimer’s is the most common form of dementia, that gets worse as it progresses which eventually leads to death. In April, Eli Lilly & Co sought to revoke a patent held by J&J in London courts, which was recently settled with Eli Lilly & Co as victor for the patent. “We are disappointed by the outcome of this case, and we are considering our options,” Greg Panico, a U.S. spokesman for Janssen. Read More